Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomized, Double-Blind Study Comparing Human Corticotropin-Releasing Factor (hCRF) to Dexamethasone for Control of Symptoms Associated With Peritumoral Brain Edema in Patients With Primary Malignant Glioma

NCT00226668 is registered in ClinicalTrials.gov with Celtic Pharma Development Services as lead sponsor.

NCT NCT00226668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00226668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomized, Double-Blind Study Comparing Human Corticotropin-Releasing Factor (hCRF) to Dexamethasone for Control of Symptoms Associated With Peritumoral Brain Edema in Patients With Primary Malignant Glioma
Lead sponsor
Celtic Pharma Development Services
Phase
Phase 3
Overall status
Withdrawn
Start date
January 31, 2006
Completion date
January 31, 2008
Enrollment
120 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

brain edema, brain tumor